The Conversation (0)
iCo Therapeutics Inc. (CVE:ICO) has appointed two new people to its board of directors. Susan Koppy and John Meekison both come to the positions with extensive experience.
iCo Therapeutics Inc. (CVE:ICO) has appointed two new people to its board of directors. Susan Koppy and John Meekison both come to the positions with extensive experience.
According to the press release:
Ms. Koppy has more than 30 years of experience in marketing and business development in the bio-pharmaceutical industry in the United States, Europe and Japan. She has participated in the negotiation of numerous agreements with a multibillion-dollar aggregate commercial value and is a frequent speaker on business development issues in the industry. After 15 years working through progressive positions of responsibility in life sciences, Ms. Koppy joined Novartis Pharmaceuticals AG in Basel, Switzerland, in 2000, where she became the first woman on the global marketing management team. Between 2005 and 2008, she built and led strategy, business development and acquisition groups for Applied Biosystems Inc., Idenix Pharmaceuticals and Transcept Pharmaceuticals, where she successfully sourced and executed a major U.S. partnership with Purdue Pharmaceuticals. Ms. Koppy now consults with a variety of bio-pharmaceutical companies on business development strategy, search and transactions in a broad variety of therapeutic areas both in- and out-licensing. She is a member of the National Association for Corporate Directors, Healthcare Businesswomen’s Association and Licensing Executive Society.
Mr. Meekison, CPA, CMA, PLog, CIM, is a co-founder and has been chief financial officer of iCo Therapeutics since February, 2005. He is a former investment banker having worked at a number of investment firms including: Loewen Ondaatje McCutcheon, Haywood Securities, Dlouhy Merchant Group and PI Financial Corp. As a financier, Mr. Meekison has raised equity capital for technology and biotechnology companies both in Canada and the United States. Mr. Meekison’s areas of expertise include: financial/treasury management, risk management, capital formation, corporate governance, mergers and acquisitions, and business strategy. Mr. Meekison sits on the board of directors of Sojourn Ventures Inc. and Natcore Technology Inc. Mr. Meekison is a chartered professional accountant, a certified investment manager and professional logistician. He received his BA from the University of British Columbia. As Ms. Koppy and Mr. Meekison join the board of directors, Doug Janzen and Noel Hall will step down, effective immediately. Mr. Janzen and Mr. Hall are thanked by the board and management for their service.
Click here to read the full press release.